Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “administration”

271 pharma patents match "administration" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 271
Index total 30,257
Page 6 / 12

Quick answer

This filtered view shows 271 pharmaceutical patents matching "administration" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

271 results for “administration” · 30,257 patents in full index Clear search

  1. US 10376525

    Treprostinil administration by inhalation

    United Therapeutics Corporation · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  2. US 10350162

    Methods and compositions for oral administration of exenatide

    Oramed Ltd. · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  3. US 10307418

    Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds

    Platform Brightworks Two, Ltd. · Granted Jun 4, 2019 · Expires May 30, 2039

    granted
  4. US 10272046

    Pharmaceutical composition and administrations thereof

    Vertex Pharmaceuticals Incorporated · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted
  5. US 10272076

    Methods for the administration of iloperidone

    VANDA PHARMACEUTICALS INC. · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted
  6. US 10265410

    Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects

    HALOZYME, INC. · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted
  7. US 10213400

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Jazz Pharmaceuticals Ireland Limited · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted
  8. US 10195214

    Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors

    Corcept Therapeutics Incorporated · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted
  9. US 10137100

    Administration of serine protease inhibitors to the stomach

    The Regents of the University of California · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  10. US 10076513

    Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  11. US 10058546

    Pharmaceutical compositions of (R)-1-(2,2-difluorobenzo[D][1,3]dioxo1-5-y1)-N-(1-(2,3-dihydroxypropy1)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-y1)-1H-indol-5-y1) cyclopropanecarbox-amide and administration thereof

    Vertex Pharmaceuticals Incorporated · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted
  12. US 10058593

    Methods and compositions for oral administration of proteins

    Oramed Ltd. · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted
  13. US 10010600

    Compositions and methods for administration of vaccines against dengue virus

    Takeda Vaccines, Inc. · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted
  14. US 9975959

    Administration of kynurenine depleting enzymes for tumor therapy

    The Board of Regents of the University of Texas System · Granted May 22, 2018 · Expires May 17, 2038

    granted
  15. US 9962366

    Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof

    Amazentis SA · Granted May 8, 2018 · Expires May 3, 2038

    granted
  16. US 9962390

    Mosapride sustained-release formulation providing pharmacological and clinical effects with once-daily administration

    KOREA UNITED PHARM. INC. · Granted May 8, 2018 · Expires May 3, 2038

    granted
  17. US 9925182

    Compositions, dosage forms, and co-administration of an opioid agonist compound and an analgesic compound

    Nektar Therapeutics · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  18. US 9914763

    VEGF antagonist formulations suitable for intravitreal administration

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  19. US 9878031

    Compositions, methods of administration and uses for trivalent dengue virus formulations

    Takeda Vaccines, Inc. · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted
  20. US 9878046

    Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects

    HALOZYME, INC. · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted
  21. US 9849100

    Pharmaceutical compositions suitable for parenteral administration comprising aqueous suspensions of benzylamine derivatives having low solubilities

    KalVista Pharmaceuticals Limited · Granted Dec 26, 2017 · Expires Dec 21, 2037

    granted
  22. US 9827223

    Selective ablation of pain-sensing neurons by administration of a vanilloid receptor agonist

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 28, 2017 · Expires Nov 23, 2037

    granted
  23. US 9808486

    Administration of kynurenine depleting enzymes for tumor therapy

    The Board of Regents of the University of Texas System · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted
  24. US 9775881

    Methods of treating mesothelioma by administration of compounds comprising FGFR1 ECD

    Five Prime Therapeutics, Inc. · Granted Oct 3, 2017 · Expires Sep 28, 2037

    granted